Calithera Biosciences and Antengene Enter Worldwide License Agreement for Development & Commercialization of CB-708

NEXT STORY
Predictmedix Announces Technology Deployment at Hockeyfest in Partnership With Jones Entertainment Group
PREV STORY
Black Diamond Therapeutics to Host Webcast Presentation of Data From Phase 1 Dose-Escalation Portion of MasterKey-01 Clinical Trial
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ViralClear Appoints Dr. Michael Sofia to Its Scientific Advisory Board

author_avatar
NASDAQ Market News

WellNow Allergy Launches to Bring Convenience and Flexibility to Allergy Testing and Immunotherapy

author_avatar
NASDAQ Market News

Checkpoint Therapeutics Announces Initiation of CONTERNO Phase 3 Trial of Cosibelimab Combined with Chemotherapy in Patients with First-Line Non-Squamous Non-Small Cell Lung Cancer

author_avatar
NASDAQ Market News